The year 2020 is a very rewarding year, in which, the new drugs independently developed by TargetRx made breakthrough progress: the next-generation Bcr-Abl inhibitor TGRX-678 for treatment of CML and the ALK/ROS1 dual inhibitor TGRX-326 for treatment of NSCLC have successively been cleared by CDE for clinical trials. At the same time, TargetRx has won several big awards this year and been recognized by the market and the industry. These awards are commendations and incentives for the efforts made by TargetRx staff in the field of first-in-class R&D and the challenge of cancer drug resistance.
Top 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macao Greater Bay Area - Pioneer Enterprise Award
On December 23, the Award Ceremony of the Top 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macao Greater Bay Area Award 2020 was held in Nansha, Guangzhou. This event was sponsored by Sino-Inno Research Institute and KPMG China, and undertaken by Guangdong Medical Valley. The 50 innovative biotechnology companies included in this year's list come from biopharmaceuticals and other fields, and they have the strength to further develop into the backbone of the Great Bay Area biotechnology industry.
TargetRx was successfully selected on the list of the top 50 innovative biotechnology companies in the Guangdong-Hong Kong-Macao Greater Bay Area and won the Pioneer Enterprise Award (sixth from right).
Top 50 Most Valuable Companies for Investment in Shenzhen
Dr. Yihan Wang: Shenzhen Top 20 Innovative Leaders
On the afternoon of December 17, the launch ceremony of the 2020 Shenzhen Innovation Enterprise List themed "New Era, New Mission, New Responsibility" came to a successful conclusion. This awards ceremony is guided by the Shenzhen Municipal People's Government, hosted by Shenzhen Media Group, Shenzhen Science and Technology Innovation Commission, and Longgang District People's Government of Shenzhen Municipality, and organized by Venture Workshop (an authoritative list survey professional agent) and Mass Innovation TV (a TV media focus on innovation and entrepreneurship) to commend the industry benchmarking enterprises for their pursuit of new changes and courage to explore under the guidance of the new era thinking.
TargetRx was successfully selected on the list of Top 50 Most Valuable Companies for Investment in Shenzhen.
At the same time, Dr. Yihan Wang, Chairman and CEO of TargetRx, won the individual award - "2020 Shenzhen Top 20 Innovation Leaders".
2020 China New Economy with Most Investment Potential Award
On December 15th, the Investment Summit 2020, hosted by Jiemian-Cailian Press under the guidance of Shanghai United Media Group, was officially opened in Shanghai with the theme of "Foresight Unbounded". At the Award Ceremony of 2020 China New Economy with Most Investment Potential and Dinner at that night, TargetRx was awarded the 2020 China New Economy with Most Investment Potential.
The winner of this award is selected based on the precise measurements of innovation, forward-looking, growth, difference, team, realization and other dimensions, combined with the basic situation of the industry, commercial value, business status, team, patented technology and other aspects. So, winning this award is a recognition of TargetRx's comprehensive strength and future development potential.
China's top 50 High-growth High-tech Companies 2020 and Rising Stars
On December 9, the China's Top 50 High-Growth High-Tech Companies 2020 and China Rising Stars lists, themed "Renaissance, Reform and Rejuvenation", were announced in the Deloitte Beijing office under the witness of dozens of media. The Rising Stars award is set up for early-stage companies that have leading technology and feasible business models, have broad growth space in the subdivision field, and are in a leading position in this field. TargetRx won the 2020 China Rising Star Award (picture below on the left).
Shenzhen Top 20 High-growth High-tech Companies 2020 and Rising Stars
Deloitte held the Shenzhen Top 20 High-Growth High-Tech Companies 2020 (Shenzhen Top 20) and Shenzhen Rising Stars award ceremony in Shenzhen on November 5. This event was hosted by Deloitte China and Shenzhen General Chamber of Commerce, undertaken by Service Bureau for Small and Medium-sized Enterprises of Shenzhen Municipality, and co-organized by Shenzhen Tian An Success Investment Development Group Co., Ltd. TargetRx won the 2020 Shenzhen Rising Star Award (picture below on the right).
Award for Outstanding Enterprise in China's Startups List
On the evening of August 31, the list of winners of the 8th China Venture Capital Golden Eagle Award selected by the Securities Times was officially announced. TargetRx won the 2020 China Venture Capital Golden Eagle Award and Award for Outstanding Enterprise in China's Startups List.
TargetRx's achievements today are inseparable from the support and help of friends from all walks of life and the government. We always keep our original aspirations in mind and strive forward to explore in R&D of new anti-cancer drugs; we have the courage to make breakthroughs and innovations, and contribute our strength to the clinical drug treatment of cancer patients and the development of the China's biopharmaceutical industry.